Peregrine Asset Advisers’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-90,591
Closed -$3.59M 178
2024
Q4
$3.59M Sell
90,591
-46,910
-34% -$1.78M 1.32% 24
2024
Q3
$4.68M Buy
+137,501
New +$3.87M 1.61% 18

Other funds holding VCYT

Peregrine Asset Advisers's VCYT Position: Q1 2025 in Review

Peregrine Asset Advisers sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 90,591 shares — an estimated $3.59M sold.

Peregrine Asset Advisers first reported a position in VCYT in Q3 2024 and held it in 2 quarters. The position peaked at $4.68M in Q3 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Peregrine Asset Advisers reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Peregrine Asset Advisers sold 90,591 Veracyte shares in Q1 2025, an estimated $3.59M.
  • Peregrine Asset Advisers first reported a position in Veracyte in Q3 2024 and held it in 2 quarters.
  • Peregrine Asset Advisers's Veracyte position peaked at $4.68M in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Peregrine Asset Advisers's 13F filing for Q1 2025, filed 5 May 2025.